AASTROM BIOSCIENCES INC (ASTM)

Overview Price 2.05 Price Change Today -$0.01 (-0.49%) P&P rating Zacks Rank 3 - HOLD Open Price $2.03 Previous Close $2.06 Daily Range $2.02 - $2.10 52-Week Range $1.75 - $3.47 Volume 141,082 Aastrom Biosciences, Inc. develops autologous cell products for the repair or regeneration of multiple human tissues, based on its proprietary Tissue Repair Cell technology. Aastrom's TRC-based products are a unique cell mixture containing stem and progenitor cell populations, produced from a small amount of bone marrow taken from the patient. TRC-based products have been used in over two hundred fourty patients, and are currently in clinical trials for bone regeneration and vascular regeneration applications. Aastrom has reported positive interim clinical trial results for TRCs suggesting both the clinical safety and the ability of TRCs to promote healing in bone regeneration applications. The Company is also developing programs for TRC-based therapies to address cardiac & neural regeneration indications. TRCs have received Orphan Drug Designation from the FDA for use in the treatment of osteonecrosis of the femoral head and the treatment of dilated cardiomyopathy, a severe chronic disease of the heart. Other Resources for ASTM Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Cytomedix Fundamentals Improving September 1, 2011 Zacks Blog: Cytomedix Fundamentals Improving September 1, 2011 Zacks Blog: Cytomedix Fundamentals Improving September 1, 2011 Zacks Blog: Cytomedix Fundamentals Improving September 1, 2011 Zacks Blog: Cytomedix Fundamentals Improving September 1, 2011 Aastrom Biosciences, Inc. develops autologous cell products for the repair or regeneration of multiple human tissues, based on its proprietary Tissue Repair Cell technology. Aastrom's TRC-based products are a unique cell mixture containing stem and progenitor cell populations, produced from a small amount of bone marrow taken from the patient. TRC-based products have been used in over two hundred fourty patients, and are currently in clinical trials for bone regeneration and vascular regeneration applications. Aastrom has reported positive interim clinical trial results for TRCs suggesting both the clinical safety and the ability of TRCs to promote healing in bone regeneration applications. The Company is also developing programs for TRC-based therapies to address cardiac & neural regeneration indications. TRCs have received Orphan Drug Designation from the FDA for use in the treatment of osteonecrosis of the femoral head and the treatment of dilated cardiomyopathy, a severe chronic disease of the heart.   Brokerage Analyst Recommendations 9 Brokerage Firms Covering ASTM   Strong Buy 5 Buy 3 Hold 1 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1.52   ASTM Ratings: BUY  SELL  HOLD ASTM Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 19 Buy 0 Sell   Top Buy Analysis BUY: ASTM Company: AASTROM BIOSCIENCES INC. Points: -17.35 Start Price: $2.64 Start Date: 04/23/2012 1:59 PM ThisColoradoKid P&P Score: 99.41 Recs: High Short Interest Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
ThisColoradoKid	99.41	04/23/12	4-23: Adds to Pick	0
AndrewGreenBull	38.99	05/27/10	Biotech Calendar: Key Dates for Wild Pennies	0
AndrewGreenBull	38.99	05/04/10	A Hot Stock to Watch: ASTM	0
Zacks_Analysts	0.00	07/27/11	Analyst Interview - International Stem Cell - Analyst Blog	0
Zacks_Analysts	0.00	11/19/10	Zacks Updates from AHA - Analyst Blog	0
Zacks_Analysts	0.00	11/08/10	Outperform On Aastrom Bio - Analyst Blog	0
Zacks_Analysts	0.00	09/22/10	Sanofi Failure Opens Door for Aastrom Bio - Analyst Blog	0
Zacks_Analysts	0.00	08/25/10	Stem Cell Confusion Creates Opportunity - Analyst Blog	0
Zacks_Analysts	0.00	08/19/10	Big Catalysts Ahead For Aastrom Bio - Analyst Blog	0
Zacks_Analysts	0.00	07/29/10	Initiating Coverage of Aastrom Bio - Analyst Blog	0

Pages: [ 1 ]  2  >>

Commentary

BUY: AASTROM BIOSCIENCES INC. (ASTM) Start Price: $2.64 Points: -17.35 Created: 04/23/2012 High Short Interest Comments: 0 | Comment ThisColoradoKid Recs:

BUY: AASTROM BIOSCIENCES INC. (ASTM) Start Price: $5.30 Points: -50.36 Created: 01/01/2008 Comments: 0 | Comment stupid Recs:

BUY: AASTROM BIOSCIENCES INC. (ASTM) Start Price: $5.30 Points: -50.36 Created: 01/01/2008 Comments: 0 | Comment abr Recs:

BUY: AASTROM BIOSCIENCES INC. (ASTM) Start Price: $5.30 Points: -50.36 Created: 01/01/2008 Comments: 0 | Comment jmany Recs:

BUY: AASTROM BIOSCIENCES INC. (ASTM) Start Price: $5.30 Points: -50.36 Created: 01/01/2008 Comments: 0 | Comment Elkman1 Recs:

BUY: AASTROM BIOSCIENCES INC. (ASTM) Start Price: $5.30 Points: -50.36 Created: 01/01/2008 Comments: 0 | Comment Teakay Recs:

BUY: AASTROM BIOSCIENCES INC. (ASTM) Start Price: $5.30 Points: -50.36 Created: 01/01/2008 Comments: 0 | Comment general76126 Recs:

BUY: AASTROM BIOSCIENCES INC. (ASTM) Start Price: $5.30 Points: -50.36 Created: 01/01/2008 Comments: 0 | Comment Slims Recs:

BUY: AASTROM BIOSCIENCES INC. (ASTM) Start Price: $5.30 Points: -50.36 Created: 01/01/2008 Comments: 0 | Comment gunner Recs:

BUY: AASTROM BIOSCIENCES INC. (ASTM) Start Price: $5.30 Points: -50.36 Created: 01/01/2008 Comments: 0 | Comment johnnyC Recs:

Pages: [ 1 ]  2  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
ThisColoradoKid	99.41	BUY	Three to Six Months	04/23/2012	$2.64	$2.09 (+2.27%)	-20.97%	-3.62%	-17.35	view close
stupid		BUY	Six Months to a Year	01/01/2008	$5.30	$2.09 (+2.27%)	-60.63%	-10.28%	-50.36
abr	48.41	BUY	Six Months to a Year	01/01/2008	$5.30	$2.09 (+2.27%)	-60.63%	-10.28%	-50.36
jmany		BUY	Six Months to a Year	01/01/2008	$5.30	$2.09 (+2.27%)	-60.63%	-10.28%	-50.36
Elkman1		BUY	Six Months to a Year	01/01/2008	$5.30	$2.09 (+2.27%)	-60.63%	-10.28%	-50.36
Teakay	87.80	BUY	Six Months to a Year	01/01/2008	$5.30	$2.09 (+2.27%)	-60.63%	-10.28%	-50.36
general76126	18.75	BUY	Six Months to a Year	01/01/2008	$5.30	$2.09 (+2.27%)	-60.63%	-10.28%	-50.36
Slims	46.21	BUY	Six Months to a Year	01/01/2008	$5.30	$2.09 (+2.27%)	-60.63%	-10.28%	-50.36
gunner	79.48	BUY	Six Months to a Year	01/01/2008	$5.30	$2.09 (+2.27%)	-60.63%	-10.28%	-50.36
johnnyC	18.75	BUY	Six Months to a Year	01/01/2008	$5.30	$2.09 (+2.27%)	-60.63%	-10.28%	-50.36

Pages: [ 1 ]  2  >>